{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:01:17Z","timestamp":1784761277999,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R24HD000836"],"award-info":[{"award-number":["R24HD000836"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Amy P. Goldman Foundation"},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH-22-1-0788"],"award-info":[{"award-number":["W81XWH-22-1-0788"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medizinische Fakult\u00e4t Heidelberg der Universit\u00e4t Heidelberg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Previous studies in adult mice indicate that the mGluR5 agonist 2-chloro-5-hydroxyphenyl glycine (CHPG), reduces cuprizone-elicited losses in myelin. This effect is partly mediated by CHPG binding to mGluR5 receptors on reactive astrocytes, triggering the release of brain derived neurotrophic factor (BDNF), which results in an increase in myelin. However, it remains unclear whether CHPG has similar beneficial effects on human oligodendrocytes. To address this issue, we examined effects of CHPG using both cultured human induced pluripotent stem cell (hiPSC)-derived oligodendrocytes and primary human fetal oligodendrocytes. We show that CHPG increases the proportion of MBP<jats:sup>+<\/jats:sup> mature oligodendrocytes without affecting survival. This effect is mediated by increasing the proliferation of oligodendrocyte precursor cells (OPCs) and enhancing differentiation in young oligodendrocytes. In contrast to observations in mice, mGluR5 expression in humans is localized on PDGFR\u03b1<jats:sup>+<\/jats:sup> OPCs and O4<jats:sup>+<\/jats:sup> immature oligodendrocytes, but not astrocytes. Using purified human OPC cultures, we show a direct effect of CHPG in increasing the proportion of MBP<jats:sup>+<\/jats:sup> mature oligodendrocytes. To identify potential cellular targets of CHPG in demyelinating disease, we analyzed postmortem tissue from individuals with chronic active multiple sclerosis (MS) and healthy controls. In contrast to the hiPSCs or primary oligodendrocytes, demyelinated white matter from MS patients shows elevated mGluR5 mRNA expression in astrocytes. Taken together, our findings suggest that CHPG enhances the differentiation of human OPCs through a mechanism distinct from that observed in cuprizone-treated mice. Moreover, astrocytes in MS pathology upregulate mGluR5, suggesting mGluR5 expression changes dynamically under disease conditions.<\/jats:p>","DOI":"10.1186\/s40478-025-02124-7","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T10:11:36Z","timestamp":1759486296000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The mGluR5 agonist CHPG enhances human oligodendrocyte differentiation"],"prefix":"10.1186","volume":"13","author":[{"given":"Yangyang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Geywitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjalika","family":"Bandaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian A","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Birth Defects Research Laboratory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Schirmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Nobuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl F","family":"Dreyfus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"issue":"3","key":"2124_CR1","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00401-020-02189-9","volume":"140","author":"K Hess","year":"2020","unstructured":"Hess K et al (2020) Lesion stage-dependent causes for impaired remyelination in MS. Acta Neuropathol 140(3):359\u2013375","journal-title":"Acta Neuropathol"},{"issue":"Pt 12","key":"2124_CR2","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1093\/brain\/awl217","volume":"129","author":"P Patrikios","year":"2006","unstructured":"Patrikios P et al (2006) Remyelination is extensive in a subset of multiple sclerosis patients. Brain 129(Pt 12):3165\u20133172","journal-title":"Brain"},{"issue":"6","key":"2124_CR3","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00401-013-1112-y","volume":"125","author":"A Boyd","year":"2013","unstructured":"Boyd A, Zhang H, Williams A (2013) Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models. Acta Neuropathol 125(6):841\u2013859","journal-title":"Acta Neuropathol"},{"issue":"2","key":"2124_CR4","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1523\/JNEUROSCI.18-02-00601.1998","volume":"18","author":"G Wolswijk","year":"1998","unstructured":"Wolswijk G (1998) Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J Neurosci 18(2):601\u2013609","journal-title":"J Neurosci"},{"issue":"Pt 12","key":"2124_CR5","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1093\/brain\/121.12.2221","volume":"121","author":"N Scolding","year":"1998","unstructured":"Scolding N (1998) Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis. Brain 121(Pt 12):2221\u20132228","journal-title":"Brain"},{"issue":"Pt 7","key":"2124_CR6","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1093\/brain\/awn096","volume":"131","author":"T Kuhlmann","year":"2008","unstructured":"Kuhlmann T et al (2008) Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 131(Pt 7):1749\u20131758","journal-title":"Brain"},{"issue":"17","key":"2124_CR7","doi-asserted-by":"publisher","first-page":"6404","DOI":"10.1523\/JNEUROSCI.20-17-06404.2000","volume":"20","author":"A Chang","year":"2000","unstructured":"Chang A et al (2000) NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 20(17):6404\u20136412","journal-title":"J Neurosci"},{"issue":"1","key":"2124_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1017\/S1740925X09000052","volume":"4","author":"YY Jean","year":"2008","unstructured":"Jean YY, Lercher LD, Dreyfus CF (2008) Glutamate elicits release of BDNF from basal forebrain astrocytes in a process dependent on metabotropic receptors and the PLC pathway. Neuron Glia Biol 4(1):35\u201342","journal-title":"Neuron Glia Biol"},{"issue":"24","key":"2124_CR9","doi-asserted-by":"publisher","first-page":"8186","DOI":"10.1523\/JNEUROSCI.4267-13.2014","volume":"34","author":"CG Fulmer","year":"2014","unstructured":"Fulmer CG et al (2014) Astrocyte-derived BDNF supports myelin protein synthesis after cuprizone-induced demyelination. J Neurosci 34(24):8186\u20138196","journal-title":"J Neurosci"},{"issue":"8","key":"2124_CR10","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1002\/glia.24003","volume":"69","author":"KS Saitta","year":"2021","unstructured":"Saitta KS et al (2021) CHPG enhances BDNF and myelination in cuprizone-treated mice through astrocytic metabotropic glutamate receptor 5. Glia 69(8):1950\u20131965","journal-title":"Glia"},{"key":"2124_CR11","doi-asserted-by":"publisher","first-page":"175909142095746","DOI":"10.1177\/1759091420957464","volume":"12","author":"Y Huang","year":"2020","unstructured":"Huang Y et al (2020) Tropomyosin receptor kinase B expressed in oligodendrocyte lineage cells functions to promote myelin following a demyelinating lesion. ASN Neuro 12:1759091420957464","journal-title":"ASN Neuro"},{"issue":"4","key":"2124_CR12","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1124\/mol.64.4.823","volume":"64","author":"P Malherbe","year":"2003","unstructured":"Malherbe P et al (2003) Mutational analysis and molecular modeling of the binding pocket of the metabotropic glutamate 5 receptor negative modulator 2-methyl-6-(phenylethynyl)-pyridine. Mol Pharmacol 64(4):823\u2013832","journal-title":"Mol Pharmacol"},{"issue":"8","key":"2124_CR13","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/nprot.2015.075","volume":"10","author":"P Douvaras","year":"2015","unstructured":"Douvaras P, Fossati V (2015) Generation and isolation of oligodendrocyte progenitor cells from human pluripotent stem cells. Nat Protoc 10(8):1143\u20131154","journal-title":"Nat Protoc"},{"issue":"2","key":"2124_CR14","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.mcn.2005.11.001","volume":"31","author":"Y Du","year":"2006","unstructured":"Du Y et al (2006) Distinct effects of p75 in mediating actions of neurotrophins on basal forebrain oligodendrocytes. Mol Cell Neurosci 31(2):366\u2013375","journal-title":"Mol Cell Neurosci"},{"issue":"4","key":"2124_CR15","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.neuron.2010.01.016","volume":"65","author":"C Luscher","year":"2010","unstructured":"Luscher C, Huber KM (2010) Group 1 mGluR-dependent synaptic long-term depression: mechanisms and implications for circuitry and disease. Neuron 65(4):445\u2013459","journal-title":"Neuron"},{"issue":"2","key":"2124_CR16","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00441-006-0266-5","volume":"326","author":"F Ferraguti","year":"2006","unstructured":"Ferraguti F, Shigemoto R (2006) Metabotropic glutamate receptors. Cell Tissue Res 326(2):483\u2013504","journal-title":"Cell Tissue Res"},{"issue":"2","key":"2124_CR17","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1471-4159.2006.04103.x","volume":"99","author":"K Luyt","year":"2006","unstructured":"Luyt K et al (2006) Oligodendroglial metabotropic glutamate receptors are developmentally regulated and involved in the prevention of apoptosis. J Neurochem 99(2):641\u2013656","journal-title":"J Neurochem"},{"issue":"6","key":"2124_CR18","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1046\/j.1471-4159.2003.01661.x","volume":"84","author":"K Luyt","year":"2003","unstructured":"Luyt K, Varadi A, Molnar E (2003) Functional metabotropic glutamate receptors are expressed in oligodendrocyte progenitor cells. J Neurochem 84(6):1452\u20131464","journal-title":"J Neurochem"},{"issue":"36","key":"2124_CR19","doi-asserted-by":"publisher","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","volume":"34","author":"Y Zhang","year":"2014","unstructured":"Zhang Y et al (2014) An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci 34(36):11929\u201311947","journal-title":"J Neurosci"},{"issue":"1","key":"2124_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neuron.2015.11.013","volume":"89","author":"Y Zhang","year":"2016","unstructured":"Zhang Y et al (2016) Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron 89(1):37\u201353","journal-title":"Neuron"},{"key":"2124_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abh2169","author":"M Karlsson","year":"2021","unstructured":"Karlsson M et al (2021) A single-cell type transcriptomics map of human tissues. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.abh2169","journal-title":"Sci Adv"},{"issue":"8","key":"2124_CR22","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1002\/jnr.21080","volume":"84","author":"Y Du","year":"2006","unstructured":"Du Y et al (2006) Mitogen-activated protein kinase pathway mediates effects of brain-derived neurotrophic factor on differentiation of basal forebrain oligodendrocytes. J Neurosci Res 84(8):1692\u20131702","journal-title":"J Neurosci Res"},{"issue":"5","key":"2124_CR23","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s11064-011-0691-z","volume":"37","author":"T Chen","year":"2012","unstructured":"Chen T et al (2012) Protective effects of mGluR5 positive modulators against traumatic neuronal injury through PKC-dependent activation of MEK\/ERK pathway. Neurochem Res 37(5):983\u2013990","journal-title":"Neurochem Res"},{"issue":"1","key":"2124_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113595","volume":"43","author":"C Lao-Peregrin","year":"2024","unstructured":"Lao-Peregrin C et al (2024) Synaptic plasticity via receptor tyrosine kinase\/G-protein-coupled receptor crosstalk. Cell Rep 43(1):113595","journal-title":"Cell Rep"},{"issue":"20","key":"2124_CR25","doi-asserted-by":"publisher","first-page":"7751","DOI":"10.1073\/pnas.0307850101","volume":"101","author":"W Deng","year":"2004","unstructured":"Deng W et al (2004) Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress. Proc Natl Acad Sci U S A 101(20):7751\u20137756","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2124_CR26","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/0306-4522(94)90428-6","volume":"61","author":"MV Catania","year":"1994","unstructured":"Catania MV et al (1994) Metabotropic glutamate receptors are differentially regulated during development. Neuroscience 61(3):481\u2013495","journal-title":"Neuroscience"},{"issue":"3","key":"2124_CR27","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/(SICI)1096-9861(19960408)367:3<403::AID-CNE6>3.0.CO;2-9","volume":"367","author":"C Romano","year":"1996","unstructured":"Romano C, van den Pol AN, O\u2019Malley KL (1996) Enhanced early developmental expression of the metabotropic glutamate receptor mGluR5 in rat brain: protein, mRNA splice variants, and regional distribution. J Comp Neurol 367(3):403\u2013412","journal-title":"J Comp Neurol"},{"issue":"4","key":"2124_CR28","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1017\/S1740925X11000111","volume":"6","author":"LL Jantzie","year":"2010","unstructured":"Jantzie LL et al (2010) Developmental regulation of group I metabotropic glutamate receptors in the premature brain and their protective role in a rodent model of periventricular leukomalacia. Neuron Glia Biol 6(4):277\u2013288","journal-title":"Neuron Glia Biol"},{"issue":"9","key":"2124_CR29","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1007\/s11064-017-2220-1","volume":"42","author":"AM Butt","year":"2017","unstructured":"Butt AM et al (2017) Metabotropic glutamate receptors protect oligodendrocytes from acute ischemia in the mouse optic nerve. Neurochem Res 42(9):2468\u20132478","journal-title":"Neurochem Res"},{"issue":"3","key":"2124_CR30","doi-asserted-by":"publisher","first-page":"R3","DOI":"10.1016\/S0014-2999(01)01157-8","volume":"424","author":"EE Kelland","year":"2001","unstructured":"Kelland EE, Toms NJ (2001) Group i metabotropic glutamate receptors limit AMPA receptor-mediated oligodendrocyte progenitor cell death. Eur J Pharmacol 424(3):R3-4","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"2124_CR31","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1002\/glia.24006","volume":"69","author":"M Tanaka","year":"2021","unstructured":"Tanaka M et al (2021) Adenosine A(2B) receptor down-regulates metabotropic glutamate receptor 5 in astrocytes during postnatal development. Glia 69(11):2546\u20132558","journal-title":"Glia"},{"issue":"6116","key":"2124_CR32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1126\/science.1226740","volume":"339","author":"W Sun","year":"2013","unstructured":"Sun W et al (2013) Glutamate-dependent neuroglial calcium signaling differs between young and adult brain. Science 339(6116):197\u2013200","journal-title":"Science"},{"issue":"7","key":"2124_CR33","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1046\/j.1460-9568.2000.00131.x","volume":"12","author":"E Aronica","year":"2000","unstructured":"Aronica E et al (2000) Upregulation of metabotropic glutamate receptor subtype mGluR3 and mGluR5 in reactive astrocytes in a rat model of mesial temporal lobe epilepsy. Eur J Neurosci 12(7):2333\u20132344","journal-title":"Eur J Neurosci"},{"issue":"4","key":"2124_CR34","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/(SICI)1098-1136(200006)30:4<352::AID-GLIA40>3.0.CO;2-6","volume":"30","author":"J Ulas","year":"2000","unstructured":"Ulas J et al (2000) Expression of metabotropic glutamate receptor 5 is increased in astrocytes after kainate-induced epileptic seizures. Glia 30(4):352\u2013361","journal-title":"Glia"},{"issue":"40","key":"2124_CR35","doi-asserted-by":"publisher","first-page":"10674","DOI":"10.1523\/JNEUROSCI.2001-07.2007","volume":"27","author":"S Ding","year":"2007","unstructured":"Ding S et al (2007) Enhanced astrocytic Ca2+ signals contribute to neuronal excitotoxicity after status epilepticus. J Neurosci 27(40):10674\u201310684","journal-title":"J Neurosci"},{"issue":"1","key":"2124_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s002210000633","volume":"137","author":"F Ferraguti","year":"2001","unstructured":"Ferraguti F et al (2001) Activated astrocytes in areas of kainate-induced neuronal injury upregulate the expression of the metabotropic glutamate receptors 2\/3 and 5. Exp Brain Res 137(1):1\u201311","journal-title":"Exp Brain Res"},{"issue":"Pt 8","key":"2124_CR37","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1093\/brain\/awg179","volume":"126","author":"JJ Geurts","year":"2003","unstructured":"Geurts JJ et al (2003) Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis. Brain 126(Pt 8):1755\u20131766","journal-title":"Brain"},{"issue":"7","key":"2124_CR38","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/glia.22502","volume":"61","author":"D Lim","year":"2013","unstructured":"Lim D et al (2013) Amyloid beta deregulates astroglial mGluR5-mediated calcium signaling via calcineurin and Nf-kB. Glia 61(7):1134\u20131145","journal-title":"Glia"},{"issue":"2","key":"2124_CR39","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0306-4522(01)00181-6","volume":"105","author":"E Aronica","year":"2001","unstructured":"Aronica E et al (2001) Immunohistochemical localization of group I and II metabotropic glutamate receptors in control and amyotrophic lateral sclerosis human spinal cord: upregulation in reactive astrocytes. Neuroscience 105(2):509\u2013520","journal-title":"Neuroscience"},{"issue":"3","key":"2124_CR40","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00401-017-1718-6","volume":"134","author":"SA Back","year":"2017","unstructured":"Back SA (2017) White matter injury in the preterm infant: pathology and mechanisms. Acta Neuropathol 134(3):331\u2013349","journal-title":"Acta Neuropathol"},{"key":"2124_CR41","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/B978-0-444-64029-1.00007-2","volume":"162","author":"J Schneider","year":"2019","unstructured":"Schneider J, Miller SP (2019) Preterm brain injury: white matter injury. Handb Clin Neurol 162:155\u2013172","journal-title":"Handb Clin Neurol"},{"issue":"7","key":"2124_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.semperi.2021.151469","volume":"45","author":"M Guillot","year":"2021","unstructured":"Guillot M, Miller SP (2021) The dimensions of white matter injury in preterm neonates. Semin Perinatol 45(7):151469","journal-title":"Semin Perinatol"},{"issue":"9","key":"2124_CR43","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1097\/MS9.0000000000000930","volume":"85","author":"P Prajjwal","year":"2023","unstructured":"Prajjwal P et al (2023) Juvenile multiple sclerosis: addressing epidemiology, diagnosis, therapeutic, and prognostic updates along with cognitive dysfunction and quality of life. Ann Med Surg (Lond) 85(9):4433\u20134441","journal-title":"Ann Med Surg (Lond)"},{"issue":"11","key":"2124_CR44","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s11910-023-01300-3","volume":"23","author":"D Castillo Villagran","year":"2023","unstructured":"Castillo Villagran D, Yeh EA (2023) Pediatric multiple sclerosis: changing the trajectory of progression. Curr Neurol Neurosci Rep 23(11):657\u2013669","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"2124_CR45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12883-018-1026-3","volume":"18","author":"R Alroughani","year":"2018","unstructured":"Alroughani R, Boyko A (2018) Pediatric multiple sclerosis: a review. BMC Neurol 18(1):27","journal-title":"BMC Neurol"},{"key":"2124_CR46","doi-asserted-by":"crossref","unstructured":"Nobuta, H., et al., Oligodendrocyte Death in Pelizaeus-Merzbacher Disease Is Rescued by Iron Chelation. Cell Stem Cell, 2019. 25(4): p. 531\u2013541 e6.","DOI":"10.1016\/j.stem.2019.09.003"},{"issue":"9","key":"2124_CR47","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41592-018-0081-4","volume":"15","author":"M Madhavan","year":"2018","unstructured":"Madhavan M et al (2018) Induction of myelinating oligodendrocytes in human cortical spheroids. Nat Methods 15(9):700\u2013706","journal-title":"Nat Methods"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02124-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-02124-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02124-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T11:03:16Z","timestamp":1759489396000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-025-02124-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2124"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-02124-7","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"19 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human brain tissues were obtained from the Birth Defects Research Laboratory at the University of Washington with ethics board approval and maternal written consent (STUDY00000380). Human brain tissues were used in the current study in accordance with ethical and legal guidelines of the Rutgers University\u2019s institutional review board (Pro2020001576). Human post-mortem brain samples with chronic active MS and healthy controls were obtained from the UK Multiple Sclerosis Tissue Bank at Imperial College London and received ethical approval from the National Research Ethics Committee in the UK (08\/MRE09\/31).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"210"}}